Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential
Clinical trial NCT02419378 · COMPLETED
Trial details
- NCT number
- NCT02419378
- Sponsor
- University Hospital Muenster
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2020-07-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.